Sichuan Huiyu Pharmaceutical Co. Ltd. Class ASSE: 688553

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 5, 2026 · Issued by Sichuan Huiyu Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Sichuan Huiyu Pharmaceutical Co. Ltd. Class A

"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Provision for Asset Impairment for the First Half of 2026Aug 22
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of HY07121 for Injection (Subcutaneous Injection)Aug 20
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Voluntary Disclosure of Obtaining Overseas Marketing Authorization for the Company's ProductsAug 11
"SICHUAN HUIYU PHARMACEUTICAL CO., LTD."Announcement on Controlled Subsidiary's Acceptance of Financial Assistance from Related PartiesAug 8

All Sichuan Huiyu Pharmaceutical Co. Ltd. Class A news releases